{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:14Z","timestamp":1761058754384,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.urolonc.2007.04.007","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T14:02:08Z","timestamp":1198677728000},"page":"266-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vesical vs. extra-vesical patterns of recurrence after the treatment of urothelial upper tract tumors"],"prefix":"10.1016","volume":"26","author":[{"given":"Sergey","family":"Shikanov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezekiel H.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer N.","family":"Gofrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2007.04.007_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1464-410X.2005.05804.x","article-title":"Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology","volume":"96","author":"Raman","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2007.04.007_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000050969","article-title":"Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract","volume":"67","author":"Koga","year":"2001","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2007.04.007_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2007.04.007_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.urology.2004.09.021","article-title":"Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract","volume":"65","author":"Matsui","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2007.04.007_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0090-4295(99)00563-4","article-title":"Risk factors for the development of bladder cancer after upper tract urothelial cancer","volume":"55","author":"Hisataki","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2007.04.007_bib6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.11691","article-title":"The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract","volume":"98","author":"Kang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2007.04.007_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0090-4295(99)80346-X","article-title":"Transitional cell carcinoma of the renal pelvis or ureter: Patterns of failure","volume":"46","author":"Cozad","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2007.04.007_bib8","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.2004.09.043","article-title":"Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: A study by the Hellenic Cooperative Oncology Group","volume":"22","author":"Bamias","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0025-6196(11)63767-1","article-title":"Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract","volume":"71","author":"Lerner","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urolonc.2007.04.007_bib10","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.1998.16.5.1844","article-title":"Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma","volume":"16","author":"Redman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-5347(17)39548-4","article-title":"Usefulness and limitations of methotrexate, vinblastine, doxorubicin, and cisplatin for the treatment of advanced urothelial cancer","volume":"144","author":"Igawa","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2007.04.007_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-1241.2005.00663.x","article-title":"Randomized phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20\/99)","volume":"60","author":"Fechner","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.urolonc.2007.04.007_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.ju.0000162039.38023.5f","article-title":"Update on chemotherapy for advanced bladder cancer","volume":"174","author":"Rosenberg","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0094-0143(03)00062-4","article-title":"Surveillance and management of recurrence for upper tract transitional cell carcinoma","volume":"30","author":"Canfield","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2007.04.007_bib16","series-title":"TNM classification of Malignant Tumors","first-page":"187","article-title":"Urinary bladder","author":"Kwiatowski","year":"1997"},{"key":"10.1016\/j.urolonc.2007.04.007_bib17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-5347(05)68582-5","article-title":"An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy","volume":"162","author":"Shipley","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1200\/JCO.1998.16.4.1298","article-title":"Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome","volume":"16","author":"Herr","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib20","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/0959-8049(95)00287-S","article-title":"Factors affecting recurrence and progression in superficial bladder tumors","volume":"31A","author":"Kurth","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2007.04.007_bib21","first-page":"483","article-title":"Primary percutaneous approach to upper urinary tract transitional cell carcinoma","volume":"16","author":"Jabbour","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2007.04.007_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0094-0143(03)00062-4","article-title":"Surveillance and management of recurrence for upper tract transitional cell carcinoma","volume":"30","author":"Canfield","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2007.04.007_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ju.0000100105.27708.6c","article-title":"Oligoclonality in bladder cancer: The implication for molecular therapies","volume":"171","author":"Duggan","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2007.04.007_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-5347(05)00057-1","article-title":"Bilateral metachronous ureteral and renal pelvic carcinomas: Incidence, clinical presentation, histopathology, treatment, and outcome","volume":"175","author":"Holmang","year":"2006","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143907001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:53:08Z","timestamp":1761040388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143907001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1078143907001287"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.04.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vesical vs. extra-vesical patterns of recurrence after the treatment of urothelial upper tract tumors","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2007.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}